Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
GSK1838705A
IGF1R
RTK
7507.098
uM
12.0880
18.40370
-0.9532 -1.0000 2.6136 0.2583
0.9872
1.0164
MDA-MB-361
HER2amp
Luminal
GSK1838705A
IGF1R
RTK
7508.071
uM
5.49120
6.97350
-0.9903 -0.9921 4.5752 0.4743
0.9876
0.8372
MDA-MB-361
HER2amp
Luminal
GSK1838705A
IGF1R
RTK
7507.07
uM
14.20950
20.63080
-0.9449 -1.0000 2.9463 0.1923
0.9946
1.0062
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
10095.001
uM
0.01185
0.56078
-0.9427 -1.0000 0.2848 0.7053
0.7348
0.9049
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
7894.001
uM
0.00171
0.00176
-0.2941 -0.0655 5.0000 0.8182
0.9150
0.7678
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
7896.001
uM
0.00127
0.00125
-0.1757 0.0463 5.0000 0.7450
0.9286
1.1912
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
9648.001
uM
0.01611
0.01774
-0.4274 -0.3105 5.0000 0.7474
0.9916
0.6289
MDA-MB-361
HER2amp
Luminal
GSK923295
CENPE
Kinesin
10095.001
uM
0.02234
0.02379
-0.1877 -0.1848 5.0000 0.6926
0.9889
0.9049
MDA-MB-361
HER2amp
Luminal
GSK923295
CENPE
Kinesin
7894.001
uM
0.03219
0.03531
-0.3372 -0.2936 5.0000 0.6871
0.9910
0.7678
MDA-MB-361
HER2amp
Luminal
GSK923295
CENPE
Kinesin
7896.001
uM
0.05334
0.05671
-0.2061 -0.1787 4.9997 0.5695
0.9949
1.1912
MDA-MB-361
HER2amp
Luminal
GSK923295
CENPE
Kinesin
9648.001
uM
0.03038
0.03448
-0.5309 -0.4420 5.0000 0.7858
0.9966
0.6289
MDA-MB-361
HER2amp
Luminal
GW-5074
CRAF
MAPK
7506.088
uM
inf
inf
0.9523 0.9523 0.0000 0.0495
0.3355
1.0417
MDA-MB-361
HER2amp
Luminal
GW843682X
PLK
PLK
10643.139
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6402
MDA-MB-361
HER2amp
Luminal
Ibandronate
FDPS
10643.143
uM
6.54950
16.83150
-0.9554 -0.9755 1.1465 0.7291
0.9827
0.4866
MDA-MB-361
HER2amp
Luminal
Ibandronate
FDPS
12379.143
uM
20.92490
37.63950
-0.9452 -0.9364 1.7974 0.5781
0.9924
0.4493
MDA-MB-361
HER2amp
Luminal
Ibandronate
FDPS
10999.143
uM
13.74950
25.12820
-0.9477 -0.9313 1.7442 0.5961
0.9979
0.5216
MDA-MB-361
HER2amp
Luminal
ICRF-193
TOP2
TOP
10999.151
uM
inf
inf
0.6771 0.6771 0.0000 0.0774
0.0387
0.7090
MDA-MB-361
HER2amp
Luminal
ICRF-193
TOP2
TOP
10643.139
uM
inf
1.44440
0.7444 0.7596 5.0000 0.0465
0.7569
0.6402
MDA-MB-361
HER2amp
Luminal
ICRF-193
TOP2
TOP
12379.157
uM
19.94190
15.33540
0.3618 0.3598 4.8411 0.0082
0.9579
0.4910
MDA-MB-361
HER2amp
Luminal
IKK16
IKK
NFKB
10472.1
uM
3.2240
4.01630
-0.9992 -0.9997 4.9985 0.4098
0.9892
0.6324
MDA-MB-361
HER2amp
Luminal
IKK16
IKK
NFKB
7506.093
uM
5.21240
6.49330
-0.9868 -1.0000 4.9995 0.3330
0.9968
0.9162
MDA-MB-361
HER2amp
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7505.09
uM
inf
6.12490
0.4003 0.5904 5.0000 0.1614
0.6629
0.6295
MDA-MB-361
HER2amp
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7506.091
uM
24.27730
34.49490
-0.9722 -0.9825 3.0942 0.4789
0.9863
1.1096
MDA-MB-361
HER2amp
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7508.091
uM
23.25790
30.52730
-0.9990 -1.0000 4.0394 0.4722
0.9925
0.6662
MDA-MB-361
HER2amp
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7507.09
uM
26.30030
34.26880
-0.9817 -0.9818 4.1049 0.3888
0.9989
1.0118